Title : ADO/hypotaurine: a novel metabolic pathway contributing to glioblastoma development.

Pub. Date : 2021 Jan 22

PMID : 33483477






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have previously identified hypotaurine as one of the top-ranked metabolites for differentiating low- and high-grade tumors, and that there is also a strong association between the levels of intratumoral hypotaurine and expression of its biosynthetic enzyme, cysteamine (2-aminoethanethiol) dioxygenase (ADO). hypotaurine 2-aminoethanethiol (cysteamine) dioxygenase Mus musculus
2 Using transcription profiling, we further uncovered that the ADO/hypotaurine axis targets CCL20 secretion through activating the NF-kappaB pathway to drive the self-renewal and maintenance of glioma "cancer stem cells" or glioma cancer stem-like cells. hypotaurine 2-aminoethanethiol (cysteamine) dioxygenase Mus musculus
3 Using transcription profiling, we further uncovered that the ADO/hypotaurine axis targets CCL20 secretion through activating the NF-kappaB pathway to drive the self-renewal and maintenance of glioma "cancer stem cells" or glioma cancer stem-like cells. hypotaurine chemokine (C-C motif) ligand 20 Mus musculus
4 Using transcription profiling, we further uncovered that the ADO/hypotaurine axis targets CCL20 secretion through activating the NF-kappaB pathway to drive the self-renewal and maintenance of glioma "cancer stem cells" or glioma cancer stem-like cells. hypotaurine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
5 Conversely, abrogating the ADO/hypotaurine axis using CRISPR/Cas9-mediated gene editing limited glioblastoma cell proliferation and self-renewal in vitro and tumor growth in vivo in an orthotopical mouse model, indicating that this metabolic pathway is a potential key therapeutic target. hypotaurine 2-aminoethanethiol (cysteamine) dioxygenase Mus musculus